One-year Outcomes of XIENCE Skypoint 48-mm Drug-Eluting Stents in Long Coronary Lesions: The SPIRIT 48 Trial

Ki E. Park, Chiung-Jen Wu,Bassem Chehab, Aziz Maksoud,Barry Bertolet, Shih-Wa Ying, Tiessa Simoes, Sandeep C. Pingle,Chi-Jen Chang

Journal of the Society for Cardiovascular Angiography & Interventions（2023）

引用 0|浏览0

暂无评分

摘要

•The treatment of long coronary lesions is challenging and encountered frequently•The availability of 48-mm drug-eluting stents in the United States has been limited•SPIRIT 48 assessed the safety/efficacy of XIENCE 48-mm in diffuse coronary disease•XIENCE 48-mm was associated with few adverse events and high procedural success

查看译文

关键词

drug-eluting stents,coronary disease,percutaneous coronary intervention

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要